Neutron and cobalt-60 gamma irradiation produce similar changes in DNA supercoiling

The effects of 60Co gamma-ray and d(20 MeV)Be neutron irradiation on DNA supercoiling have been studied using a nucleoid rewinding technique. Irradiation of viable CHO AA8 cells on ice with from 4 to 25 Gy of either radiation produced a similar resistance to rewinding of nuclear supercoils after treatment with ethidium bromide. The restitution from the effects of 12 Gy of either radiation was also similar, leaving no detectable residual damage. The discrepancy between these data and the reduced ability of neutrons to produce DNA breaks, as defined by the alkaline elution assay, is explained by the discontinuous deposition of dose associated with neutron irradiation. It is suggested from a microdosimetric analysis that the neutron radiation interacts with DNA at sites on average 5-10 times further apart than the interactions with gamma rays. The long DNA sequences which results after neutron irradiation are consequently eluted inefficiently during alkaline elution, giving a reported RBE of approximately 0.3. Restrictions in the rewinding of individual supercoils are not dependent on the interionization distance and thus give rise to an RBE of approximately 1. Furthermore, the complete removal of DNA damage, as measured by this technique, supports the hypothesis that neutron toxicity is associated with incorrect, not incomplete, rejoining of the DNA molecule.     

In vivo measurement of bone aluminium: recent developments

A biomarker of aluminium accumulation in the human body can play a valuable role in determining health effects of chronic aluminium exposure, complementing other human and environmental monitoring data. In vivo neutron activation provides such a non-invasive biomarker. To date, the best in vivo neutron activation system used thermalised neutrons from a nuclear reactor at Brookhaven National Laboratory, which suffered only slightly from interference from other elements, primarily phosphorus, and from the disadvantage of restricted accessibility. At McMaster, we use a nuclear reaction on an accelerator to select neutron energy, which eliminates the interferences. Spectral decomposition analysis improved sensitivity. A new 4pi detection system also enhanced sensitivity. Together these improvements yield a minimum detection limit of 0.24 mgAl in a hand, slightly better than at Brookhaven and equivalent to "normal" levels. Further improvements should result from a new irradiation cavity and from using a higher proton current on the accelerator to shorten irradiation times. The system is now ready for pilot human studies.     

In-vivo and in-vitro measurements of lead and cadmium

Tibia lead is measured in vivo using X-ray fluorescence. A¹⁰⁹Cd source is used to excite Pb K X-rays, and this signals is normalized to that from Rayleigh scattering to remove geometrical variations. The lower limit of detection is 10 μg/g for a mean absorbed dose, to the exposed section of the leg, of 100 μGy. Tibia lead correlated positively with age in normal volunteers (r=0.615,p=0.004) and with duration of exposure in occupationally exposed subjects (r=0.847,p=0.0001). When the X-ray fluorescence technique was applied to autopsy specimens previously analyzed by atomic absorption spectrometry there was excellent agreement between measurement techniques. Cadmium is measured in vivo by neutron activation analysis. The detection limit in liver is 6.5 μg/g for a local skin dose equivalent of 0.5 mSv and in kidney is 6.4 mg for a dose equivalent of 0.9 mSv to the skin. Detailed analysis of the γ-ray spectrum will produce only slight improvements in detection limit. Uncertainties in organ position during measurement, even after ultrasonic localization, are likely to produce uncertainties of 20–25% in cadmium measurement. Autopsy samples were measured, using a fast neutron activation method, from people previously measured in vivo. The results are broadly consistent, but show differences greater than those accounted for by counting statistics.     

Noninvasive measurement of aluminium in human bone: Preliminary human study and improved system performance

Aluminium has been measured in the hands of 18 referent subjects and six aluminium welders using the technique of in vivo neutron activation analysis. The minimal detection limit (MDL) in the human subjects was 28.0 μgAl/gCa, whereas it was 19.5 μgAl/gCa in calibration standards. On average the aluminium exposed subjects had higher levels of aluminium in their hands than did the referent subjects. However, this difference only just achieved significance at the 5% level and should be treated with caution, since the study had not been deliberately designed to assess this difference. Following the preliminary human study, improvements were made to the measurement system with respect to the gamma-ray detector array and to the timing sequence of irradiation-transfer-counting. These improvements were tested on the calibration standards, lowering the MDL from 19.5 μgAl/gCa to 8.32 μgAl/gCa. A similar improvement in human measurements would result in an in vivo MDL of 12.0 μgAl/gCa.     

In vivo neutron activation analysis of organ cadmium burdens

In vivo neutron activation measurements of liver and kidney cadmium have been mae in 77 exposed workers and 101 referents. Cadmium levels were higher in exposed workers than in referents; both in liver, 25.7 cf. 0.6 μg/g, and kidney, 17.9 cf. 2.7 mg. The 19 referents who never smoked had lower mean organ cadmium burdens than the other referents, the difference achieving statistical significance in the kidney,p<.01. Cigaret smoking was estimated to increase cadmium body burden by 370-140 μg/pack year. These referent cadmium levels are similar to, although slightly below, previous in vivo and autopsy data.